The differential effects of statins on the metastatic behaviour of prostate cancer

British Journal of Cancer

Volumn 106, Issue 10, 2012, Pages 1689-1696

  Brown, M ^a   Hart, C ^a   Tawadros, T ^a   Ramani, V ^b,c   Sangar, V ^b,c   Lau, M ^b,d   Clarke, N ^a,b,d  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b CHRISTIE HOSPITAL   (United Kingdom)

^c MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^d SALFORD ROYAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Bone marrow stroma; Metastasis; Prostate cancer; Statins

Indexed keywords

ATORVASTATIN; CHOLESTEROL; COMPACTIN; GERANYLGERANYL PYROPHOSPHATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVALONIC ACID; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

ARTICLE; BONE MARROW STROMA; CELL CULTURE; CELL MIGRATION; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; METASTASIS; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; STROMA; TUMOR VOLUME;

BONE MARROW; CELL LINE, TUMOR; CELL MOVEMENT; EPITHELIAL CELLS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; POLYISOPRENYL PHOSPHATES; PROSTATIC NEOPLASMS;

EID: 84860702956     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2012.138     Document Type: Article

References (32)

1. Boudreau DM, Yu O, Miglioretti DL, Buist DS, Heckbert SR, Daling JR (2007) Statin use and breast cancer risk in a large population-based setting. Cancer Epidemiol Biomarkers Prev 16: 416-421 (Pubitemid 46548643)
2. Breau RH, Karnes RJ, Jacobson DJ, McGree ME, Jacobsen SJ, Nehra A, Lieber MM, St Sauver JL (2010) The association between statin use and the diagnosis of prostate cancer in a population based cohort. J Urol 184: 494-499
3. Brown MD, Hart C, Gazi E, Gardner P, Lockyer N, Clarke N (2010) Influence of omega-6 PUFA arachidonic acid and bone marrow adipocytes on metastatic spread from prostate cancer. Br J Cancer 102: 403-413
4. Brown MD, Hart CA, Gazi E, Bagley S, Clarke NW (2006) Promotion of prostatic metastatic migration towards human bone marrow stoma by Omega 6 and its inhibition by Omega 3 PUFAs. Br J Cancer 94: 842-853
5. Campbell MJ, Esserman LJ, Zhou Y, Shoemaker M, Lobo M, Borman E, Baehner F, Kumar AS, Adduci K, Marx C, Petricoin EF, Liotta LA, Winters M, Benz S, Benz CC (2006) Breast cancer growth prevention by statins. Cancer Res 66: 8707-8714 (Pubitemid 44449187)
6. Coutinho LH, Gilleece MH, de Wynter E, Will A, Testa NG (1993) Clonal and long-term cultures using human bone marrow. In Haemopoiesis: A Practical Approach, Testa NG, Molineux G (eds), pp 75-106. Oxford University Press: Oxford
7. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 (Internet). International Agency for Research on Cancer: Lyon, France, 2010
8. Garwood S (2010) Statins and cardiac surgery. J Cardiothorac Vasc Anesth 24: 909-912
9. George NJ (1988) Natural history of localised prostatic cancer managed by conservative therapy alone. Lancet 1: 494-497 (Pubitemid 18059682)
10. Gutt R, Tonlaar N, Kunnavakkam R, Karrison T, Weichselbaum RR, Liauw SL (2010) Statin use and risk of prostate cancer recurrence in men treated with radiation therapy. J Clin Oncol 28: 2653-2659
11. Hager MH, Solomon KR, Freeman MR (2006) The role of cholesterol in prostate cancer. Curr Opin Clin Nutr Metab Care 9: 379-385 (Pubitemid 44097806)
12. Hart C, Clarke N, Brown M (2006) Analysis of prostate tumour cell invasion using BD FluoroBlok and FLUOstar OPTIMA. BMG Labtech Application Notes 144
13. Hart CA, Brown M, Bagley S, Sharrard M, Clarke NW (2005) Invasive characteristics of human prostatic epithelial cells: understanding the metastatic process. Br J Cancer 92: 503-512 (Pubitemid 40395531)
14. Kotamraju S, Williams CL, Kalyanaraman B (2007) Statin-induced breast cancer cell death: role of inducible nitric oxide and arginase-dependent pathways. Cancer Res 67: 7386-7394 (Pubitemid 47206569)
15. Koyuturk M, Ersoz M, Altiok N (2007) Simvastatin induces apoptosis in human breast cancer cells: p53 and estrogen receptor independent pathway requiring signalling through JNK. Cancer Lett 250: 220-228 (Pubitemid 46529446)
16. Lang SH, Clarke NW, George NJ, Allen TD, Testa NG (1998) Interaction of prostate epithelial cells from benign and malignant tumor tissue with bone-marrow stroma. Prostate 34: 203-213 (Pubitemid 28156611)
17. Loeb S, Kan D, Helfand BT, Nadler RB, Catalona WJ (2010) Is statin use associated with prostate cancer aggressiveness? BJU Int 105: 1222-1225
18. Merck (2005) Information for Prescribers. Merck Sharp & Dohme Ltd: Cramlington, Northumberland, UK.
19. Mondul AM, Clipp SL, Helzlsouer KJ, Platz EA (2010) Association between plasma total cholesterol concentration and incident prostate cancer in the CLUE II cohort. Cancer Causes Control 21: 61-68
20. Murtola TJ, Tammela TL, Maattanen L, Huhtala H, Platz EA, Ala-Opas M, Stenman UH, Auvinen A (2010) Prostate cancer and PSA among statin users in the Finnish prostate cancer screening trial. Int J Cancer 127: 1650-1659
21. Najib NM, Idkaidek N, Adel A, Admour I, Astigarraga RE, Nucci GD, Alam SM, Dham R, Qumaruzaman (2003) Pharmacokinetics and bioequivalence evaluation of two simvastatin 40 mg tablets (Simvast and Zocor) in healthy human volunteers. Biopharm Drug Dispos 24: 183-189 (Pubitemid 36939689)
22. Platz EA, Clinton SK, Giovannucci E (2008) Association between plasma cholesterol and prostate cancer in the PSA era. Int J Cancer 123: 1693-1698
23. Platz EA, Leitzmann MF, Visvanathan K, Rimm EB, Stampfer MJ, Willett WC, Giovannucci E (2006) Statin drugs and risk of advanced prostate cancer. J Natl Cancer Inst 98: 1819-1825 (Pubitemid 46017933)
24. Sanz-Moreno V, Gadea G, Ahn J, Paterson H, Marra P, Pinner S, Sahai E, Marshall CJ (2008) Rac activation and inactivation control plasticity of tumor cell movement. Cell 135: 510-523
25. Scott LJ, Clarke NW, George NJ, Shanks JH, Testa NG, Lang SH (2001) Interactions of human prostatic epithelial cells with bone marrow endothelium: binding and invasion. Br J Cancer 84: 1417-1423 (Pubitemid 32522114)
26. Solomon KR, Freeman MR (2008) Do the cholesterol-lowering properties of statins affect cancer risk? Trends Endocrinol Metab 19: 113-121 (Pubitemid 351608305)
27. Stancu C, Sima A (2001) Statins: mechanism of action and effects. J Cell Mol Med 5: 378-387
28. Thibault A, Samid D, Tompkins AC, Figg WD, Cooper MR, Hohl RJ, Trepel J, Liang B, Patronas N, Venzon DJ, Reed E, Myers CE (1996) Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer. Clin Cancer Res 2: 483-491
29. van der Spek E, Bloem AC, van de Donk NW, Bogers LH, van der Griend R, Kramer MH, de Weerdt O, Wittebol S, Lokhorst HM (2006) Dose-finding study of high-dose simvastatin combined with standard chemotherapy in patients with relapsed or refractory myeloma or lymphoma. Haematologica 91: 542-545
30. Wu H, Jiang H, Lu D, Xiong Y, Qu C, Zhou D, Mahmood A, Chopp M (2009) Effect of simvastatin on glioma cell proliferation, migration, and apoptosis. Neurosurgery 65: 1087-1096; discussion 1096-1097
31. Zhao TT, Le Francois BG, Goss G, Ding K, Bradbury PA, Dimitroulakos J (2010) Lovastatin inhibits EGFR dimerization and AKT activation in squamous cell carcinoma cells: potential regulation by targeting rho proteins. Oncogene 29: 4682-4692
32. Zhuang L, Kim J, Adam RM, Solomon KR, Freeman MR (2005) Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts. J Clin Invest 115: 959-968 (Pubitemid 40489400)